Aspira Women's Health (AWH)
(Delayed Data from NSDQ)
$0.80 USD
+0.01 (1.76%)
Updated Sep 25, 2024 03:59 PM ET
After-Market: $0.80 0.00 (0.03%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth A Momentum B VGM
Price, Consensus and EPS Surprise
AWH 0.80 +0.01(1.76%)
Will AWH be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for AWH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for AWH
Dorsata's Alliance on Adnexal Masses to Support Aspira Stock
Aspira (AWH) Reports Q2 Loss, Misses Revenue Estimates
AWH: What are Zacks experts saying now?
Zacks Private Portfolio Services
DarioHealth Corp. (DRIO) Q2 Earnings Beat Estimates
Aspira (AWH) Reports Q1 Loss, Tops Revenue Estimates
Masimo (MASI) Beats Q4 Earnings and Revenue Estimates
Other News for AWH
Aspira Women’s Health Engages Investors with Performance Insights
Aspira Women's Health announces publication of data on blood test
Aspira Women?s Health Announces Publication of Data Demonstrating Performance of its In-Development Blood Test for the Assessment of Malignancy Risk in Patients with an Adnexal Mass
Aspira Women?s Health to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Aspira Women?s Health Selected as a Spoke for the Investor Catalyst Hub